Bernstein analyst Stacy Rasgon downgrades Lam Research (NASDAQ:LRCX) from Outperform to Market Perform.
What 4 Analyst Ratings Have To Say About Axsome Therapeutics
Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings within the last quarter: